Global Point of Care Diagnostics Market was valued at USD 32.91 billion in 2022 and is expected to reach USD 63.67 billion by the year 2030, at a CAGR of 8.6%.
Point-of-care testing (POCT) is critical for detecting analytes close to the patient, allowing for better disease diagnosis, monitoring, and management. It allows for quick medical decisions because diseases can be diagnosed at an early stage, resulting in better health outcomes for patients by allowing for the early start of treatment. POC testing was first used in 1962 with the development of a method for rapid analysis of blood glucose, and soon after, in 1977, rapid pregnancy tests were developed, ushering in a trend for personalized diagnostics.
Request a Free Sample of Point of Care Diagnostics Market:
https://introspectivemarketresearch.com/request/16302
Key Companies & Market Share Insights:
· F. Hoffmann-La Roche Ltd (Basel, Switzerland)
· Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
· Abbott Laboratories (Illinois, U.S.)
· Quest Diagnostics Incorporated (New Jersey, U.S.)
· BD (Franklin Lakes, U.S.)
· BioMerieux SA (Marcy l'Etoile, France)
· Cardinal Health, Inc. (Ohio, U.S.)
· Mesa Biotech (California, U.S.)
· Cepheid (California, U.S.)
· Trinity Biotech (Bray, Ireland)
· Quidel Corporation (San Diego, U.S.)
· Bio-Rad Laboratories Inc. (California, U.S.) and Other Major Players.
The latest research on the Point of Care Diagnostics Market provides a comprehensive overview of the market for the years 2023 to 2030. It gives a comprehensive picture of the global Point of Care Diagnostics Market industry, considering all significant industry trends, market dynamics, competitive landscape, and market analysis tools such as Porter's five forces analysis, Industry Value chain analysis, and PESTEL analysis of the Point of Care Diagnostics Market. Moreover, the report includes significant chapters such as Patent Analysis, Regulatory Framework, Technology Roadmap, BCG Matrix, Heat Map Analysis, Price Trend Analysis, and Investment Analysis which help to understand the market direction and movement in the current and upcoming years. The report is designed to help readers find information and make decisions that will help them grow their businesses. The study is written with a specific goal in mind: to give business insights and consultancy to help customers make smart business decisions and achieve long-term success in their particular market areas.
Get Discount on Full Report of Point of Care Diagnostics Market:
https://introspectivemarketresearch.com/discount/16302
Point of Care Diagnostics Market is Segmented as follows:
· Infectious Disease Testing Products
· Glucose Monitoring Products
· Pregnancy
· Fertility Testing Products
· Cardiometabolic Monitoring Products
· Others
By Platform
· Molecular Diagnostic
· Immunoassays
· Lateral Flow Assays
· Others
By End-User
· Hospitals
· Clinics
· Diagnostic Laboratories
· Home Care
· Others
Point of Care Diagnostics Market Regional Analysis/Insights:
§ North America (U.S., Canada, Mexico)
§ Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
§ Western Europe (Germany, U.K., France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
§ Asia-Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
§ Middle East & Africa (Turkey, Saudi Arabia, Bahrain, Kuwait, Qatar, UAE, Israel, South Africa)
§ South America (Brazil, Argentina, Rest of SA)
If You Have Any Query Point of Care Diagnostics Market Report, Visit:
https://introspectivemarketresearch.com/inquiry/16302
In addition to investigating market intricacies, our study focuses extensively on the holistic ecosystem of the Point of Care Diagnostics Market. We analyse the functions and interdependencies of diverse market stakeholders, offering insights into their roles within the industry. Furthermore, our wide-ranging geographical coverage facilitates a profound understanding of regional trends. Our study features in-depth company profiles and competitive analysis, providing invaluable insights into market players' overview, market role, operating business segments, and financial performance. Through the evaluation of critical metrics like production volume, sales volume, and sales margin, we establish a comprehensive understanding of their market position.
Quick Buy Point of Care Diagnostics Market - Opportunity Analysis and Industry Forecast (2023-2030), Research:
https://introspectivemarketresearch.com/checkout/?user=1&_sid=16302
Frequently Asked Questions:
· What would be the forecast period in the Point of Care Diagnostics Market research report?
· The forecast period in the Point of Care Diagnostics Market research report is 2023-2030.
· Who are the key players in Point of Care Diagnostics Market?
· F. Hoffmann-La Roche Ltd (Basel, Switzerland), Thermo Fisher Scientific Inc. (Massachusetts, U.S.), Abbott Laboratories (Illinois, U.S.), Quest Diagnostics Incorporated (New Jersey, U.S.), BD (Franklin Lakes, U.S.), BioMerieux SA (Marcy l'Etoile, France), Cardinal Health, Inc. (Ohio, U.S.), Mesa Biotech (California, U.S.), Cepheid (California, U.S.), Trinity Biotech (Bray, Ireland), Quidel Corporation (San Diego, U.S.), Bio-Rad Laboratories Inc. (California, U.S.) and other major players.
· What are the segments of the Point of Care Diagnostics Market?
· The Point of Care Diagnostics Market is segmented into Application, Platform, End-User, and region. By Application, the market is categorized into Infectious Disease Testing Products, Glucose Monitoring Products, Pregnancy, and Fertility Testing Products, Cardiometabolic Monitoring Products, and Others. By Platform, the market is categorized into Molecular Diagnostic, Immunoassays, Lateral Flow Assays, and Others. By End-User, the market is categorized into Hospitals, Clinics, Diagnostic Laboratories, Home Care, Others. By region, it is analyzed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain, etc.), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
· What is the Point of Care Diagnostics Market?
· Point-of-care testing (POCT) is critical for detecting analytes close to the patient, allowing for better disease diagnosis, monitoring, and management. It allows for quick medical decisions because diseases can be diagnosed at an early stage, resulting in better health outcomes for patients by allowing for the early start of treatment.
· How big is the Point of Care Diagnostics Market?
· Global Point of Care Diagnostics Market was valued at USD 32.91 billion in 2022 and is expected to reach USD 63.67 billion by the year 2030, at a CAGR of 8.6%.
https://introspectivemarketresearch.com/reports/blood-urea-nitrogen-diagnostics-market/
https://introspectivemarketresearch.com/reports/influenza-diagnostics-market/
https://introspectivemarketresearch.com/reports/blood-transfusion-diagnostics-market/
About us:
Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.
Contact us:
Introspective Market Research
3001 S King Drive,
Chicago, Illinois
60616 USA
Email : sales@introspectivemarketresearch.com
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek